Oncology & Cancer

Engineering a cancer-fighting virus

Hokkaido University researchers have engineered a virus that selectively targets and kills cancer cells. The virus, called dl355, has an even stronger anticancer effect than another engineered virus currently used in clinical ...

Oncology & Cancer

Melanoma: dabrafenib and trametinib have added benefit

The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug combinations of dabrafenib plus trametinib and of encorafenib plus binimetinib have an added benefit in comparison with ...

Oncology & Cancer

Fat fuels aggressive brain cancers

Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.

Oncology & Cancer

Blood vessel-forming cells involved in aggressive brain tumour

A type of highly malignant brain tumour contains a large number of cells involved in the formation of new blood vessels, helping it proliferate and spread. Targeting these cells could hinder tumour growth, according to new ...

Oncology & Cancer

Breaking through a tumor's defenses

In research published today, Babraham Institute researchers have shown that some tumours use not one but two levels of protection against the immune system. Knocking out one level boosted the protective effects of the second ...

Oncology & Cancer

Anti-inflammatory strategy stops aggressive childhood cancer

Researchers at Karolinska Institutet and Karolinska University Hospital have discovered that an anti-inflammatory drug candidate inhibiting the prostaglandin E2 producing enzyme mPGES-1 in the tumour stroma reduces tumour ...

Oncology & Cancer

Better equipped in the fight against lung cancer

Lung cancer is the third-most common type of cancer in Germany, affecting both men and women. However, immunotherapies are successful in only 20 percent of cases. Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg ...

page 1 from 12